Clincosm LogoSign in Get a demo

adenocarcinoma

Showing 26 - 50 of 170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)

Active, not recruiting
  • Pancreatic Cancer
  • Adenocarcinoma
  • Hamilton, Ontario, Canada
  • +3 more
May 12, 2022

Adenocarcinoma, Prostate Tumors, Prostate Cancer Trial run by the National Institutes of Health Clinical Center (CC) (EM

Enrolling by invitation
  • Adenocarcinoma
  • +4 more
  • EM Tracking
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

Recruiting
  • Lung Neoplasm Malignant
  • +18 more
  • Fairfax, Virginia
    New Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

PRIMER: Development of Daily Online Magnetic Resonance Imaging

Recruiting
  • Adenocarcinoma
  • Imaging
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust
Mar 2, 2022

Gastroesophageal Cancer, Adenocarcinoma Trial in United States (Pembrolizumab, Abemaciclib)

Active, not recruiting
  • Gastroesophageal Cancer
  • Adenocarcinoma
  • Indianapolis, Indiana
  • +3 more
Feb 16, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

Active, not recruiting
  • Pancreatic Cancer
  • +4 more
  • Paricalcitol (Zemplar)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 16, 2022

Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

Recruiting
  • Neuroendocrine Tumor
  • +4 more
  • Cabozantinib 40 mg
  • Badalona, Barcelona, Spain
  • +14 more
Feb 15, 2022

NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 8, 2022

Adenocarcinoma, Prostate Cancer Trial in Lake Success (Stereotactic Body Radiation Therapy)

Completed
  • Adenocarcinoma
  • Prostate Cancer
  • Stereotactic Body Radiation Therapy
  • Lake Success, New York
    North Shore-LIJ Cancer Institute
Feb 7, 2022

Rates of Esophageal Cancer in Women Taking Medications for

Completed
Has Results
  • Esophageal Cancer
  • +2 more
  • (no location specified)
Feb 1, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Gastrointestinal Tumors, Adenocarcinoma Trial in Worldwide (IMU-131, Cisplatin and either Fluorouracil (5-FU) or Capecitabine or

Active, not recruiting
  • Gastrointestinal Neoplasms
  • Adenocarcinoma
  • IMU-131
  • Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine.
  • Tbilisi, Georgia
  • +21 more
Jan 19, 2022

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Lung Tumors, Carcinoma Non-small-cell Lung, Adenocarcinoma Trial in Rochester (Multifocal Lung Adenocarcinoma)

Active, not recruiting
  • Lung Neoplasms
  • +2 more
  • Multifocal Lung Adenocarcinoma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 3, 2021

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated
Has Results
  • Non-Small Cell Lung Cancer
  • +3 more
  • Tucson, Arizona
  • +34 more
Oct 11, 2021

Clinical Management of Esophageal Adenocarcinoma (EAC)

Active, not recruiting
  • Esophageal Cancer
  • Adenocarcinoma
  • serum and tissue mesothelin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 1, 2021

Cancer, Squamous Cell Carcinoma, Adenocarcinoma Trial in Utrecht (esophagectomy with three-field lymphnode dissection)

Completed
  • Cancer
  • +3 more
  • esophagectomy with three-field lymphnode dissection
  • Utrecht, Netherlands
    UMC Utrecht
Sep 28, 2021

Breast Cancer, Adenocarcinoma Trial in Switzerland (Eribulin mesilate)

Terminated
  • Breast Cancer
  • Adenocarcinoma
  • Eribulin mesilate
  • Aarau, Switzerland
  • +25 more
Sep 27, 2021

Adenocarcinoma, Lung Tumor Trial in Korea, Republic of (Pemebit, Cisplatin)

Completed
  • Adenocarcinoma
  • Lung Neoplasm
  • Hwasun, Jeonnam, Korea, Republic of
  • +6 more
Aug 1, 2021

Isolating and Testing Circulating Tumor DNA and Soluble Immune

Completed
  • Lung Cancer
  • +10 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 19, 2021

    SERum-bank for PANcreatic Cancer

    Recruiting
    • Adenocarcinoma
    • Blood sample
    • Saint-Priest-en-Jarez, France
    • +1 more
    Jul 16, 2021

    Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis, Nashville (X-82, Everolimus)

    Terminated
    Has Results
    • Adenocarcinoma
    • Pancreatic Neoplasms
    • Saint Louis, Missouri
    • +1 more
    Jun 15, 2021

    Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,

    Recruiting
    • Pancreatic Adenocarcinoma
    • +2 more
    • Chicago, Illinois
      The University of Chicago
    Jun 7, 2021